Goczalkowice Zdroj, Poland

Investigate Efficacy and Safety of Carisbamate As Adjunctive Treatment for Seizures Associated with LGS in Children and Adults

The secondary objectives are: - To evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the total number of seizures compared with placebo in pediatric and adult subjects diagnosed with Lennox Gastaut Syndrome (LGS) - Evaluate the safety, tolerability of carisbamate in the LGS population - Evaluate steady-state pharmacokinetics of carisbamate in subjects with Lennox Gastaut.